A new compound targets energy generation, thereby killing metastatic cells

October 17, 2017, Bar-Ilan University

Cancer can most often be successfully treated when confined to one organ. But a greater challenge lies in treating cancer that has metastasized, or spread, from the primary tumor throughout the patient's body. Although immunotherapy can be effective in treating the metastatic phase of the disease, it is still applicable to a limited number of patients.

Prof. Uri Nir, of the Mina and Everard Goodman Faculty of Life Sciences at Bar-Ilan University, and his team have identified an enzyme that supports the survival and dissemination of metastatic cells, and developed a that targets the enzyme and kills the metastatic cells in mice with cancer. Their research has just been published in the journal Nature Communications.

When leaving the , cancer cells possess greater tools to survive in very harsh conditions, such as shortage of basic nutrients like glucose. Metastatic cells can safeguard against this metabolic deficiency by reprogramming their energy generation system. Prof. Nir and his team found the existence of an enzyme (FerT) in the mitochondria (an organ which generates energy within the cells) of cancer cells that they couldn't find in the mitochondria of normal cells. When they targeted the enzyme in the laboratory, the failed to produce energy and died. The team then began searching for the enzyme elsewhere in the body. They detected it in only one specific cell - none other than .

Sperm cells are the only cells in our body which exert their functions outside our body. "Like metastatic cells, sperm cells are unique in that they can also generate energy under very harsh conditions. Once they have entered the female birth canal, where there is no blood supply for them, they produce and expend enormous amounts of energy under very extreme or abnormal conditions," explains Prof. Nir. "We found that very aggressive metastatic cancer cells looked for and identified this sperm specific protein, learned how to produce it and harnessed it in order to potentiate their mitochondria and produce energy under very harsh conditions."

Using advanced chemical and robotic approaches, the team developed a synthetic compound which can be administered orally or by injection to animals or patients. When applied to metastatic cells in culture or mice with , the compound, called E260, enters the and then into the mitochondria ("power station"). It then binds the enzyme FerT, distorts its activity and, quite notably, not only inhibits its activity, but as a result of the inhibition causes a complete collapse of the entire mitochondria power station.

Metastatic are very capable, says Nir. When they identify the damage to the mitochondria power station they start to activate a recycling process (termed autophagy) aimed at decomposing and rebuilding mitochondria. This recycling process, however, requires a lot of energy and this ongoing energy consumption leads to a severe depletion, metabolic crisis and death of the metastatic. "We have treated mice with metastatic cancer and this compound completely cured them with no adverse or toxic affect that we can see. We have also checked several and they are not affected," says Nir.

Prof. Nir and team have now shown that not only do sperm initiate life, but also carry with them the potential to terminate life. They hope to pursue Phase 1 clinical trials within a year-and-a-half.

Explore further: Mitochondrial metastasis suppressor pathway controls tumor cell metabolic reprogramming

More information: Yoav Elkis et al, A novel Fer/FerT targeting compound selectively evokes metabolic stress and necrotic death in malignant cells, Nature Communications (2017). DOI: 10.1038/s41467-017-00832-w

Related Stories

Mitochondrial metastasis suppressor pathway controls tumor cell metabolic reprogramming

September 11, 2017
A novel mitochondrial variant of the protein Syntaphilin, or SNPH, which orchestrates the choice between cancer cell proliferation and metastasis in response to oxygen and nutrient shortage in the tumor microenvironment, ...

Mitochondria drive cell survival in times of need

September 21, 2017
McGill University researchers have discovered a mechanism through which mitochondria, the energy factory of our body's cells, play a role in preventing cells from dying when the cells are deprived of nutrients - a finding ...

PD-L1 mainly expressed in metastatic CRC lesions

September 19, 2017
(HealthDay)—Programmed death-ligand 1 (PD-L1) is primarily expressed in metastatic colorectal cancer (CRC) lesions, according to a study published online Aug. 29 in the Journal of Digestive Diseases.

Chemical array draws out malignant cells to guide individualized cancer treatment

May 26, 2017
Melanoma is a particularly difficult cancer to treat once it has metastasized, spreading throughout the body. University of Illinois researchers are using chemistry to find the deadly, elusive malignant cells within a melanoma ...

Mitochondria are exploited in cancer for tumor cell motility and metastatic competence

July 7, 2016
As the powerhouse of the cells, mitochondria are critical for every organism because of their role in producing energy while also controlling survival, but how they function in cancer is still not completely known. This is ...

New bone-in technique tests therapies for breast cancer metastasis

April 21, 2017
A new laboratory technique developed by researchers at Baylor College of Medicine and other institutions can rapidly test the effectiveness of treatments for life-threatening breast cancer metastases in bone. The study appears ...

Recommended for you

Researchers identify blood biomarkers that may help diagnose, confirm concussions

April 20, 2018
Researchers from the University of California, Irvine, Georgetown University and the University of Rochester have found that specific small molecules in blood plasma may be useful in determining whether someone has sustained ...

DOR protein deficiency favors the development of obesity

April 20, 2018
Obesity is a world health problem. Excessive accumulation of fat tissue (adipose tissue) increases the risk of cardiovascular disease, hypertension, diabetes and some types of cancer. However, some obese individuals are less ...

Stem-cell technology aids 3-D printed cartilage repair

April 20, 2018
Novel stem-cell technology developed at Swinburne will be used to grow the massive number of stem cells required for a new hand-held 3-D printer that will enable surgeons to create patient-specific bone and cartilage.

Enduring cold temperatures alters fat cell epigenetics

April 19, 2018
A new study in fat cells has revealed a molecular mechanism that controls how lifestyle choices and the external environment affect gene expression. This mechanism includes potential targets for next-generation drug discovery ...

Defect in debilitating neurodegenerative disease reversed in mouse nerves

April 19, 2018
Scientists have developed a new drug compound that shows promise as a future treatment for Charcot-Marie-Tooth disease, an inherited, often painful neurodegenerative condition that affects nerves in the hands, arms, feet ...

Molecule that dilates blood vessels hints at new way to treat heart disease

April 19, 2018
Americans die of heart or cardiovascular disease at an alarming rate. In fact, heart attacks, strokes and related diseases will kill an estimated 610,000 Americans this year alone. Some medications help, but to better tackle ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.